FDA Hearing on Psychedelic Medicine Reveals a Field Divided on the Road to Approval—Psychiatric Times
Source ↗
👁 0
💬 0
Read article—Amber Barnato, a professor of medicine, testified Monday at an FDA public hearing on psychedelic therapies, pointing to evidence that psilocybin-assisted treatment can produce durable reductions in depression, anxiety and demoralization among patients facing life-threatening illness, but that more research is required.
Comments (0)